Variant report
Variant | nsv8919 |
---|---|
Chromosome Location | chr12:11425363-11434135 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:16)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:16 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | FOS | chr12:11426499-11426683 | MCF10A-Er-Src | breast: | n/a | chr12:11426623-11426633 chr12:11426623-11426633 chr12:11426624-11426631 chr12:11426624-11426633 |
2 | FOS | chr12:11433334-11433357 | MCF10A-Er-Src | breast: | n/a | n/a |
3 | FOS | chr12:11426502-11426755 | MCF10A-Er-Src | breast: | n/a | chr12:11426623-11426633 chr12:11426623-11426633 chr12:11426624-11426631 chr12:11426624-11426633 |
4 | FOS | chr12:11433639-11433673 | MCF10A-Er-Src | breast: | n/a | n/a |
5 | FOS | chr12:11426495-11426749 | MCF10A-Er-Src | breast: | n/a | chr12:11426623-11426633 chr12:11426623-11426633 chr12:11426624-11426631 chr12:11426624-11426633 |
6 | FOS | chr12:11426490-11426749 | MCF10A-Er-Src | breast: | n/a | chr12:11426623-11426633 chr12:11426623-11426633 chr12:11426624-11426631 chr12:11426624-11426633 |
7 | MAFF | chr12:11433777-11433859 | K562 | blood: | n/a | n/a |
8 | MAFF | chr12:11433654-11433885 | HepG2 | liver: | n/a | n/a |
9 | MAFK | chr12:11433631-11433886 | IMR90 | lung: | n/a | chr12:11433769-11433789 |
10 | MAFK | chr12:11433616-11433932 | HepG2 | liver: | n/a | chr12:11433769-11433789 |
11 | MAFK | chr12:11433704-11433891 | HepG2 | liver: | n/a | chr12:11433769-11433789 |
12 | MAZ | chr12:11433806-11433916 | HepG2 | liver: | n/a | n/a |
13 | POLR2A | chr12:11426329-11426415 | A549 | lung: | n/a | n/a |
14 | RFX5 | chr12:11430723-11430748 | K562 | blood: | n/a | n/a |
15 | STAT3 | chr12:11426954-11427033 | MCF10A-Er-Src | breast: | n/a | n/a |
16 | STAT3 | chr12:11426521-11426733 | MCF10A-Er-Src | breast: | n/a | chr12:11426623-11426632 chr12:11426597-11426605 |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
PRB3 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs141012092 | chr12:11425377-11425378 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs12316372 | chr12:11425379-11425380 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs563886127 | chr12:11425388-11425389 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs532534448 | chr12:11425416-11425417 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs56101939 | chr12:11425424-11425425 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs559394121 | chr12:11425438-11425439 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs61604574 | chr12:11425449-11425450 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs367600854 | chr12:11425450-11425451 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs398044271 | chr12:11425451-11425452 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs145532089 | chr12:11425468-11425469 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs397691563 | chr12:11425474-11425475 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs11054211 | chr12:11425475-11425476 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs367922002 | chr12:11425494-11425495 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs528470263 | chr12:11425497-11425498 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs527558531 | chr12:11425513-11425514 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs185546466 | chr12:11425618-11425619 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs549556523 | chr12:11425626-11425627 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs568309779 | chr12:11425640-11425641 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs201261583 | chr12:11425646-11425647 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs188777843 | chr12:11425664-11425665 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs76870242 | chr12:11425676-11425677 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs550535126 | chr12:11425712-11425713 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs570640676 | chr12:11425733-11425734 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs539228107 | chr12:11425734-11425735 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs553105637 | chr12:11425761-11425762 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs7980324 | chr12:11425774-11425775 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs535481006 | chr12:11425854-11425855 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs550734485 | chr12:11425878-11425879 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs373599473 | chr12:11425942-11425943 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs192035400 | chr12:11425952-11425953 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs184226271 | chr12:11425967-11425968 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs555402109 | chr12:11426028-11426029 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs575061493 | chr12:11426056-11426057 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs367765994 | chr12:11426100-11426101 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs563796588 | chr12:11426114-11426115 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs577391089 | chr12:11426135-11426136 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs372154132 | chr12:11426177-11426178 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs545946927 | chr12:11426273-11426274 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs112847000 | chr12:11426325-11426326 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs145680731 | chr12:11426329-11426330 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs188640076 | chr12:11426343-11426344 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs562096957 | chr12:11426345-11426346 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs148935221 | chr12:11426361-11426362 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs55707460 | chr12:11426372-11426373 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs181045576 | chr12:11426381-11426382 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs111941423 | chr12:11426471-11426472 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs546805214 | chr12:11426486-11426487 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs112397010 | chr12:11426507-11426508 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs535523986 | chr12:11426508-11426509 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs57906285 | chr12:11426547-11426548 | Weak transcription Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 17690704 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Ovine squamous-cell carcinoma | 17599052 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
T-cell acute lymphoblastic leukemia | 20065082 | CNVD |
Breast cancer | 22032731 | CNVD |
Cancer | 21183584 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Prostate cancer | 21965145 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Liposarcoma | 21253554 | CNVD |
Prostate cancer | 19156837 | CNVD |
Emphysema | 19352772 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Malignant germ cell tumour | 17285132 | CNVD |
Melanoma | 18172304 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Wilms tumour | 21544195 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Breast cancer | 21264507 | CNVD |
Cancer | 16751803 | CNVD |
Testicular cancer | 18059402 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Seminomas | 18059402 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Malaria | 21533027 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 21858162 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21785460 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21611746 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Lung cancer | 18438408 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Squamous cell cancer | 19607727 | CNVD |
Prostate cancer | 16573809 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Acute myeloid leukemia | 17268525 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Prostate cancer | 16461572 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Breast cancer | 17133270 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Acute myeloid leukemia | 17237825 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 22522925 | CNVD |
Mental retardation | 20877625 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
Non-syndromic sensorineural hearing loss | 19812545 | CNVD |
small cell lung cancer | 20016488 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Autism | 20531469 | CNVD |
Cancer | 20164920 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr12:11407400-11440200 | Weak transcription | Primary T cells from cord blood | blood |
2 | chr12:11425000-11432400 | Weak transcription | Fetal Adrenal Gland | Adrenal Gland |
3 | chr12:11426200-11427000 | Enhancers | HMEC | breast |
4 | chr12:11429800-11433800 | Weak transcription | Liver | Liver |
5 | chr12:11430600-11433200 | Weak transcription | Left Ventricle | heart |
6 | chr12:11431000-11431200 | Active TSS | Adipose Nuclei | Adipose |
7 | chr12:11431000-11433200 | Weak transcription | Primary T cells fromperipheralblood | blood |
8 | chr12:11431200-11433400 | Weak transcription | Adipose Nuclei | Adipose |
9 | chr12:11432400-11433000 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
10 | chr12:11433400-11434000 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
11 | chr12:11433400-11434200 | Strong transcription | Adipose Nuclei | Adipose |
12 | chr12:11433800-11434000 | ZNF genes & repeats | Liver | Liver |